🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 16 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/12/2023 | 94,98 | 95,97 | 94,58 | 95,54 | +1,71% | 1,46% | 883.500 |
| 18/12/2023 | 93,99 | 94,50 | 92,09 | 93,93 | +1,01% | 2,56% | 1.280.200 |
| 15/12/2023 | 94,49 | 95,50 | 91,60 | 92,99 | -1,62% | 4,13% | 3.385.300 |
| 14/12/2023 | 93,83 | 96,55 | 93,28 | 94,52 | +2,62% | 3,49% | 1.831.500 |
| 13/12/2023 | 87,00 | 92,47 | 87,00 | 92,11 | +6,11% | 6,29% | 1.478.500 |
| 12/12/2023 | 88,73 | 88,91 | 86,23 | 86,81 | -1,03% | 3,02% | 820.500 |
| 11/12/2023 | 87,52 | 88,10 | 85,61 | 87,71 | +0,78% | 2,85% | 1.228.900 |
| 08/12/2023 | 88,13 | 89,65 | 87,01 | 87,03 | -1,56% | 3,00% | 614.000 |
| 07/12/2023 | 87,89 | 90,00 | 87,03 | 88,41 | +1,18% | 3,38% | 689.900 |
| 06/12/2023 | 88,64 | 89,01 | 86,28 | 87,38 | -0,86% | 3,08% | 2.014.700 |
| 05/12/2023 | 85,08 | 89,32 | 83,97 | 88,14 | +2,35% | 6,29% | 1.153.300 |
| 04/12/2023 | 84,38 | 86,94 | 84,00 | 86,12 | +1,99% | 3,48% | 1.318.700 |
| 01/12/2023 | 81,28 | 84,50 | 78,67 | 84,44 | +3,89% | 7,17% | 1.319.400 |
| 30/11/2023 | 81,01 | 81,90 | 80,22 | 81,28 | +1,09% | 2,07% | 1.269.600 |
| 29/11/2023 | 82,72 | 83,50 | 80,14 | 80,40 | -2,68% | 4,06% | 1.135.200 |
| 28/11/2023 | 81,97 | 82,90 | 81,60 | 82,61 | +0,04% | 1,59% | 927.800 |
| 27/11/2023 | 82,50 | 84,04 | 81,64 | 82,58 | -0,35% | 2,91% | 651.600 |
| 24/11/2023 | 83,83 | 84,23 | 82,28 | 82,87 | -1,07% | 2,33% | 394.800 |
| 22/11/2023 | 84,42 | 85,23 | 82,06 | 83,77 | -0,37% | 3,76% | 606.900 |
| 21/11/2023 | 85,03 | 85,40 | 83,42 | 84,08 | +1,23% | 2,33% | 1.013.100 |
| 20/11/2023 | 83,00 | 85,94 | 82,62 | 83,06 | -0,11% | 4,00% | 1.376.700 |
| 17/11/2023 | 82,98 | 85,50 | 82,77 | 83,15 | +0,20% | 3,29% | 1.434.400 |
| 16/11/2023 | 83,08 | 83,43 | 81,18 | 82,98 | -0,93% | 2,71% | 1.408.700 |
| 15/11/2023 | 81,77 | 84,71 | 81,46 | 83,76 | +1,53% | 3,97% | 1.172.600 |
| 14/11/2023 | 81,93 | 82,56 | 80,68 | 82,50 | +3,55% | 2,29% | 1.655.000 |
| 13/11/2023 | 79,74 | 80,30 | 76,61 | 79,67 | +0,28% | 4,63% | 882.600 |
| 10/11/2023 | 78,81 | 79,66 | 76,25 | 79,45 | +0,38% | 4,33% | 1.270.000 |
| 09/11/2023 | 79,88 | 80,26 | 75,85 | 79,15 | -1,91% | 5,52% | 2.080.000 |
| 08/11/2023 | 82,93 | 83,47 | 80,40 | 80,69 | -2,70% | 3,70% | 1.076.100 |
| 07/11/2023 | 80,62 | 84,19 | 80,62 | 82,93 | +3,53% | 4,43% | 2.180.600 |